share_log

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K:重大事件
美股sec公告 ·  06/05 15:02
Moomoo AI 已提取核心信息
On June 5, 2024, Novo Integrated Sciences, Inc. announced that its subsidiary, Acenzia Inc., has been chosen by Protein Industries Canada to participate in a project aimed at introducing new protein products with enhanced nutritional profiles to the global market. The project, with a total investment of approximately $5.4 million, will focus on the development, reformulation, and commercialization of three consumer-ready protein products. Acenzia will contribute around $600,000, while Protein Industries Canada and two other partner companies will invest $2.3 million and $2.5 million, respectively. The initiative will span three phases and aims to offer plant-based protein alternatives that are comparable to whey protein isolate in terms of quality, sensory experience, and muscle health benefits. The products are intended for various consumer segments, including...Show More
On June 5, 2024, Novo Integrated Sciences, Inc. announced that its subsidiary, Acenzia Inc., has been chosen by Protein Industries Canada to participate in a project aimed at introducing new protein products with enhanced nutritional profiles to the global market. The project, with a total investment of approximately $5.4 million, will focus on the development, reformulation, and commercialization of three consumer-ready protein products. Acenzia will contribute around $600,000, while Protein Industries Canada and two other partner companies will invest $2.3 million and $2.5 million, respectively. The initiative will span three phases and aims to offer plant-based protein alternatives that are comparable to whey protein isolate in terms of quality, sensory experience, and muscle health benefits. The products are intended for various consumer segments, including medical nutrition, active living, and high-performance sports. Acenzia's involvement leverages its expertise in contract manufacturing, product formulation, R&D, and sustainable packaging to create ecologically friendly, evidence-based plant protein products. Novo Integrated Sciences, Inc., the parent company, is known for its multidisciplinary healthcare ecosystem and product innovation, focusing on a holistic approach to health and wellness.
2024年6月5日,Novo Integrated Sciences公司宣布其子公司Acenzia公司被Protein Industries Canada选中参与一个旨在为全球市场引进新的增强营养剖面的蛋白质产品项目。该项目总投资约540万美元,将专注于开发、重组和商业化三种消费者准备好的蛋白质产品。Acenzia公司将贡献约60万美元,而Protein Industries Canada和其他两家合作伙伴公司将分别投资230万美元和250万美元。这项计划将分为三个阶段,并旨在提供植物基蛋白质替代品,其品质、感官体验和肌肉健康效益可与乳清蛋白分离物相媲美。这些产品适用于各种消费者群体,包括医疗...展开全部
2024年6月5日,Novo Integrated Sciences公司宣布其子公司Acenzia公司被Protein Industries Canada选中参与一个旨在为全球市场引进新的增强营养剖面的蛋白质产品项目。该项目总投资约540万美元,将专注于开发、重组和商业化三种消费者准备好的蛋白质产品。Acenzia公司将贡献约60万美元,而Protein Industries Canada和其他两家合作伙伴公司将分别投资230万美元和250万美元。这项计划将分为三个阶段,并旨在提供植物基蛋白质替代品,其品质、感官体验和肌肉健康效益可与乳清蛋白分离物相媲美。这些产品适用于各种消费者群体,包括医疗营养、积极生活和高性能运动。Acenzia公司的参与利用其在合同制造、产品配方、研发和可持续包装方面的专业知识,以创造生态友好、基于证据的植物蛋白制品。Novo Integrated Sciences公司,作为母公司,以其多学科的医疗保健生态系统和产品创新而闻名,专注于健康和健康全面的方法。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息